STSA Latest Press Releases, Satsuma Pharmaceuticals, Inc. Corporate News

Releases

1.100

0.00%

0.000

All
Financials
Insiders

8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
05/18/2023 12:30
10-Q | Satsuma Pharmaceuticals, Inc.(0001692830)
05/11/2023 12:08
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
05/03/2023 12:12
SC 13D/A | Satsuma Pharmaceuticals, Inc.(0001692830)
05/02/2023 13:27
10-K/A | Satsuma Pharmaceuticals, Inc.(0001692830)
04/28/2023 12:13
SC 13D/A | Satsuma Pharmaceuticals, Inc.(0001692830)
04/18/2023 12:31
SC 13D/A | Satsuma Pharmaceuticals, Inc. (0001692830)
04/17/2023 12:09
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
04/17/2023 03:00
10-K | Satsuma Pharmaceuticals, Inc.(0001692830)
03/28/2023 12:55
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
03/28/2023 12:54
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
02/16/2023 11:04
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
02/14/2023 08:45
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
02/10/2023 11:20
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
02/08/2023 11:57
SC 13D/A | Satsuma Pharmaceuticals, Inc.(0001692830)
01/27/2023 11:58
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
12/20/2022 11:22
4/A | Satsuma Pharmaceuticals, Inc.(0001692830)
12/09/2022 11:12
UPLOAD | Satsuma Pharmaceuticals, Inc.(0001692830)
12/07/2022 02:55
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
11/30/2022 11:02
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
11/23/2022 04:39
SC 13G | Satsuma Pharmaceuticals, Inc.(0001692830)
11/16/2022 11:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
11/16/2022 11:39
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
11/16/2022 11:14
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
11/16/2022 11:14
3 | Satsuma Pharmaceuticals, Inc.(0001692830)
11/16/2022 11:00
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
11/14/2022 11:16
EFFECT | Satsuma Pharmaceuticals, Inc.(0001692830)
11/08/2022 01:35
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
11/03/2022 12:55
424B5 | Satsuma Pharmaceuticals, Inc.(0001692830)
11/03/2022 12:54
10-Q | Satsuma Pharmaceuticals, Inc.(0001692830)
11/03/2022 12:32
CORRESP | Satsuma Pharmaceuticals, Inc. (0001692830)
11/03/2022 12:10
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
11/03/2022 12:06
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
10/28/2022 12:04
S-3 | Satsuma Pharmaceuticals, Inc.(0001692830)
10/28/2022 02:12
8-K | Satsuma Pharmaceuticals, Inc. (0001692830)
09/20/2022 13:03
10-Q | Satsuma Pharmaceuticals, Inc.(0001692830)
08/09/2022 12:30
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
08/09/2022 12:20
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 13:38
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
06/07/2022 02:40
10-Q | Satsuma Pharmaceuticals, Inc. (0001692830)
05/10/2022 12:19

Webull provides the latest Satsuma Pharmaceuticals, Inc. (STSA) stock and general news. This information may help you make smarter investment decisions.

About STSA

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a therapeutic product for the acute treatment of migraine. The Company's product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate (DHE), which is designed to self-administered with a pre-filled, single-use, nasal delivery device. STS101 also incorporates an improved 2nd-generation nasal delivery device. STS101 is specifically designed to deliver the clinical advantages of DHE while overcoming its shortcomings.